Visceral leishmaniasis complicated by hemophagocytic lymphohistiocytosis: A case report from a nonendemic area.

acute medicine allergy and immunology infectious diseases

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
May 2023
Historique:
received: 28 10 2022
revised: 01 04 2023
accepted: 17 04 2023
medline: 8 5 2023
pubmed: 8 5 2023
entrez: 8 5 2023
Statut: epublish

Résumé

Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many features in common and may coincide in the same patient. Timely diagnosis and management of visceral leishmaniasis could save patients from unnecessary toxic treatment. Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many clinical features in common and may coexist in the same patient. Visceral leishmaniasis should be promptly ruled out in patients coming from endemic areas before starting immunosuppressive therapy for hemophagocytic lymphohistiocytosis. The mainstay treatment, in this case, is anti-leishmania medications preferably liposomal amphotericin-B.

Identifiants

pubmed: 37151937
doi: 10.1002/ccr3.7309
pii: CCR37309
pmc: PMC10160431
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e7309

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors have no conflict of interest to declare.

Références

Pediatr Infect Dis J. 2015 Dec;34(12):1311-4
pubmed: 26780020
Wkly Epidemiol Rec. 2016 Jun 3;91(22):287-96
pubmed: 27263128
Clin Infect Dis. 2014 May;58(10):1424-9
pubmed: 24585564
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
J Infect. 2008 May;56(5):381-8
pubmed: 18405976
J Drug Target. 1993;1(4):311-6
pubmed: 8069573
Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S82-9
pubmed: 19932759
Clin Pharmacokinet. 1992 Oct;23(4):279-91
pubmed: 1395361
Medicine (Baltimore). 2007 Jan;86(1):26-38
pubmed: 17220753
J Pediatr. 2014 Jul;165(1):147-153.e1
pubmed: 24797953
Clin Infect Dis. 2016 Dec 15;63(12):1539-1557
pubmed: 27941143
Blood. 2002 Oct 1;100(7):2367-73
pubmed: 12239144
BMJ. 2002 Jul 27;325(7357):176-7
pubmed: 12142292

Auteurs

Anwar I Joudeh (AI)

Department of Internal Medicine, Al-Khor Hospital Hamad Medical Corporation Doha Qatar.

Hussein A Elsiddig Awadelkarim (HA)

Department of Internal Medicine, Al-Khor Hospital Hamad Medical Corporation Doha Qatar.

Mohammadshah Isam Gul (MI)

Department of Internal Medicine, Hamad General Hospital Hamad Medical Corporation Doha Qatar.

Mahmoud Salm Elayana (MS)

Department of Internal Medicine, Hamad General Hospital Hamad Medical Corporation Doha Qatar.

Dina Sameh Soliman (DS)

Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar.

Aliaa Amer (A)

Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar.

Musaed Alsamawi (M)

Department of Internal Medicine, Infectious Diseases Division, Al-Khor Hospital Hamad Medical Corporation Doha Qatar.

Classifications MeSH